Agus, David (Ellison Institute for Transformative Medicine 202205 Co-Founder) |
Company Founder |
Lawrence J. Ellison Institute for Transformative Medicine |
United States (USA) |
Ahanola, Jani (Noona Healthcare 201611 CEO) |
Chief Executive Officer (CEO) |
Noona Healthcare (FI) |
Finland |
Ahlberg, Christer (Cinclus Pharma 202106– CEO before Sedana Medical Group) |
Chief Executive Officer (CEO) |
Cinclus Pharma (Group) |
Sweden |
Ahlberg, Christopher (Spotfire 200505 CEO) |
Chief Executive Officer (CEO) |
TIBCO Software (Group) |
United States (USA) |
Ahlers, Benedikt (Florenus AG 200912– Executive Director + Founder before IP Bewertungs AG Head Sales + Developm) |
Board member, executive |
Florenus AG |
Germany |
Ahlers, Sabine |
n. a. |
DEWB AG |
Germany |
Ahmadi, Khatereh (Merck (US) 201810 Executive Director Business Development + Licensing) |
Business Development Manager / Strategy Manager |
Merck (US) (MSD) (Group) |
United States (USA) |
Ahmati, Besmire (Gilde Investment 202306– Associate IR + Fundraising at Gilde Healthcare before PGGM + FMO) |
Public Relations Manager / Investor Relations Manager |
Gilde Investment (Group) |
Netherlands |
Ahmed, J. Omee (Alto Marketing 201512) |
Public Relations Manager / Investor Relations Manager |
Alto Marketing Ltd. |
United Kingdom (GB) |
Ahmed, Nadim (BMS 202109 EVP) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
Ahnfeld, Oliver (Provirex 201911– Managing Director) |
Managing Director |
Provirex Genome Editing Therapies GmbH |
Germany |
Ahomäki, Satu (Orion Corp 202001 SVP Commercial Operations) |
Chief Commercial Officer (CCO) |
Orion Corporation (Group) |
Finland |
Ahrens, Brent (Canaan Partners 201603 General Partner) |
General Partner (venture partner) |
Canaan Partners (Group) |
United States (USA) |
Ahrens, Nikolai (Turos Capital 2018– Founder + CEO + LifeScience Connect 2020 Founder) |
n. a. |
Turos Capital AG |
Switzerland |
Ahrent, Esther (Olympus Life + Material Science Europa GmbH 200704 Section Manager Marketing Comm Microscopy) |
n. a. |
Olympus (Group) |
Germany |
Aiach, Karen (Lysogene 201206 CEO + Founder) |
Chief Executive Officer (CEO) |
Lysogene S.A. (Euronext Paris: LYS) |
France |
Aigner, Ilse (Germany (govt) 201101 Minister BMELV) |
Minister |
Germany (govt) |
Germany |
Aiguabella Font, Nuria (Bayer 202108 Global Communications Bayer Pharma New Modalities) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
Aiolfi, Franco (Biohit 201304– CEO of Biohit Italy before EuroClone) |
Chief Executive Officer (CEO) |
Biohit (Group) |
Italy |
Aisher, Patrick (Kinled 202104 at Kinled Austria) |
Investment Manager |
Kinled (Group) |
Austria |
Aithani, Lakshyaditya Singh (Laksh) (Charm Therapeutics 202206 CEO + Co-Founder before Braavos + Exscientia + genei) |
Chief Executive Officer (CEO) |
Charm Therapeutics Ltd. |
United Kingdom (GB) |
Aitkenhead, Mark (Element Biosciences 202205– Chief Commercial Officer before at Thermo Fisher since 2003) |
Chief Commercial Officer (CCO) |
Element Biosciences Inc. |
United States (USA) |
Aitman, Tim (CSC/Imperial College London 200503) |
Professor |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
Aivaliotis, Michalis (FORTH 201202 IMBB-FORTH) |
n. a. |
FORTH (Foundation for Research and Technology – Hellas) |
Greece |
Aiwanger, Hubert (Bavaria (govt) 201904 State Minister of Economic Affairs + Regional Development + Energy) |
Minister |
Bavaria (govt region) |
Germany |
Akatsuka, Hiroyuki (Osaka (govt) 202210 Associate Director of Life Sciences Industry Division) |
Administrative Officer (personnel) |
Osaka (govt region) |
Japan |
Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director) |
Managing Director |
Hadean Ventures AS |
Norway |
Akhmedov, Murodzhon (BigOmics 202203 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BigOmics Analytics S.A. |
Switzerland |
Akira, Shizuko (Osaka (govt) 202210 President of OSaka Bio Headquarters) |
Cluster Manager |
Osaka (govt region) |
Japan |
Akkaraju, Srinivas (Srini) (Samsara BioCaptial 2016– Founder before Sofinnova Ventures + New Leaf Venture Partners) |
Investment Manager |
Samsara BioCapital (US) |
United States (USA) |
Akkerman, Ina (mei:do concepts GmbH 201211 Director Marketing + Communication before Norgenta) |
Public Relations Manager / Investor Relations Manager |
mei:do concepts GmbH |
Germany |
Akkermans, Michel |
n. a. |
|
|
Al-Halabi-Frenzel, Laila (Abcalis GmbH 202312 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Abcalis GmbH |
Germany |
Al-Khattawi, Ali (Mesox 2021– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Olgram SAS |
France |
Al-Olayan, Abdurahman (Dammam Valley 202209 CEO) |
Chief Executive Officer (CEO) |
Saudi Arabia (govt) |
Saudi Arabia |
Al-Wakeel, Yasir (Kronos Bio 202008– CFO + Head of CorpDev before Neon Therapeutics + Merrimack Pharma + Credit Suisse) |
Chief Financial Officer (CFO) |
Kronos Bio Inc. (Nasdaq: KRON) |
United States (USA) |
Alajmovic, Sana (Sigrid Therapeutics 201909 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sigrid Therapeutics AB |
Sweden |
Alamaa, Marie-Louise (PledPharma 202011 CFO) |
Chief Financial Officer (CFO) |
Egetis Therapeutics (Group) |
Sweden |
Alambeigi, Behrouz (Genetek Biopharma 201805 Managing Director + Co-Founder) |
Managing Director |
Genetek Biopharma GmbH |
Germany |
Alanine, Alexander (Bactevo 201704– COO before Roche) |
Chief Operating Officer (COO) |
Astellas (Group) |
United Kingdom (GB) |
Alatovic, Jasmina (BioNTech 202005 Senior Manager Global External Communications) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Germany |
Alavijeh, Mohammad (Pharmidex 200602 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pharmidex Pharmaceutical Services Ltd. |
United Kingdom (GB) |
Alba, Florent (NewCap 201502) |
Public Relations Manager / Investor Relations Manager |
NewCap. – Investor Relations & Financial Communications |
France |
Albani, Stephan (Univ Oldenburg 201101 Managing Director HörTech gGmbH + Hörzentrum Oldenburg GmbH) |
Managing Director |
University of Oldenburg (Carl von Ossietzky University) |
Germany |
Albayrak, Celal (ALRISE Biosystems 201005 Managing Director) |
Managing Director |
Alrise Biosystems GmbH |
Germany |
Alberich-Bayarri, Ángel (Quibim 202301 CEO + Founder) |
Chief Executive Officer (CEO) |
Quibim S.L. |
Spain (España) |
Alberici, Gilles (Orega Biotech 201601 CEO before Octalfa 2009 President before OPi SA founder + president) |
Chief Executive Officer (CEO) |
Orega Biotech (FR) |
France |
Alberici, Luca (Asahi Glass 202403 General Manager + Managing Director at AGC Biologics Italy before MolMed 201903 CBO) |
Chief Business Officer (CBO) |
Asahi Glass (AGC) (Group) |
Italy |
Albermann, Kaj (Biomax Informatics 201804 Project Manager) |
Support Manager / Service Manager |
Biomax (Group) |
Germany |
Albers, Jeffrey W. (Jeff) (Blueprint Medicinces 201201– President of Algeta US + Genzyme + Mintz Levin) |
Chief Executive Officer (CEO) |
Blueprint Medicines (Group) |
United States (USA) |
Albert, Matthew (Institut Pasteur 201501 Director of Immunology Dept) |
President/Director/Head of Research Organisation/Unit |
Institut Pasteur |
France |
Albert, Winfried (AdnaGen 200810 Managing Director before COO + CSO) |
Managing Director |
Qiagen (Group) |
Germany |
Albertella, Mark (Storm Therapeutics 201905– VP Translational Oncology before Medivir + Argenta + OSI Pharmaceuticals) |
Research & Development Manager |
Storm Therapeutics Ltd. |
United Kingdom (GB) |
Alberti, Claudio (GenomSys 201909 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
GenomSys S.A. |
Switzerland |
Albiach Martí, María R. (Valgenetics S.L. 201504 Founder+ Executive Director) |
Company Founder |
Valgenetics S.L. |
Spain (España) |
Albiez, Michael (Zeiss 202303 Head of Zeiss Research Microscopy Solutions) |
President/Director/Head Business Group/Unit/Division |
Carl Zeiss (Group) |
Germany |
Albiez, Peter (Pfizer 202007 Country Manager Germany) |
Regional manager |
Pfizer (Group) |
Germany |
Albig, Torsten (Schleswig-Holstein (govt) 201703 Minister President) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
Albinus, Bjørn (Cheminova 200504 Managing Director) |
Managing Director |
Auriga Industries (Group) |
Denmark |
Albisser, Zeno (Hemispherian 202105 CEO) |
Chief Executive Officer (CEO) |
Hemispherian AS |
Norway |
Albou, Laurent-Philippe (Bionext 2009– CEO + Co-founder) |
Company Founder |
Bionext (FR) |
France |
Albou, Serge-Henri (Bionext 2009– CEO + Co-founder) |
Chief Executive Officer (CEO) |
Bionext (FR) |
France |
Albrecht, Claudio (Actavis 201201 CEO) |
Chief Executive Officer (CEO) |
Teva (Group) |
Iceland |
Albrecht, Klaus-Dieter (Synexus 201303– Managing Director fo Synexus Germany) |
Managing Director |
Synexus (Group) |
Germany |
Albrecht, Uwe (Mediconomics 201704 Managing Director) |
Managing Director |
Mediconomics GmbH |
Germany |
Albrecht, Wolfgang (HepaRegenix 201602– Managing Director) |
Managing Director |
HepaRegenix GmbH |
Germany |
Albrechtsen, Morten (Nanovi ApS 201311 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Nanovi A/S |
Denmark |
Albright, Kristen (Prokarium 202010– promoted to COO) |
Chief Operating Officer (COO) |
Prokarium Ltd. |
United Kingdom (GB) |
Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH) |
Chief Executive Officer (CEO) |
Hookipa (Group) |
Austria |
Aldeguer, Xavier (Trueta Hospital 201601 Head of Digestion Unit + Co-Founder of GoodGut) |
Researcher (university / research institute) |
University of Gerona (UdG, University of Girona) |
Spain (España) |
Alder, Matthias (Autolus 201707– CBO + General Counserl before Sucampp + Cytos Biotechnology + Micromet + Cooley LLP) |
Chief Business Officer (CBO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
Aleksik, Jelena (PharmEnable 202012 CBO before GeneAdviser) |
Chief Business Officer (CBO) |
PharmEnable Ltd. |
United Kingdom (GB) |
Alem, Liza (AZMed 202402 Head of Marketing + Communication) |
Sales Manager / Marketing Manager |
AZmed SAS |
France |
Alenfall, Jan (Follicum 201902 CEO) |
Chief Executive Officer (CEO) |
Follicum AB |
Sweden |
Aleotti, Alberto Giovanni (Menarini 201210 Board Member of A. Menarini) |
Board member |
Menarini (Group) |
Italy |
Aleotti, Lucia (Menarini 201611 Group Chairman) |
Chief Executive Officer (CEO) |
Menarini (Group) |
Italy |
Alessandri, Kévin (TreeFrog Therapeutics 202201– Managing Director TreeFrog Tx Inc before CEO + CTO + Co-Founder) |
Chief Executive Officer (CEO) |
TreeFrog Therapeutics (Group) |
United States (USA) |
Alevizopoulos, Konstantinos (APIM Therapeutics 201210 CEO) |
Chief Executive Officer (CEO) |
APIM Therapeutics AS |
Norway |
Alexakis, Domenico P. (Swiss Biotech Association 201611 CEO) |
Chief Executive Officer (CEO) |
Swiss Biotech Association (SBA) |
Switzerland |
Alexander, David (Adecco 201709 President North America Financa, Office + Healthcare businesses) |
President/Director/Head Business Group/Unit/Division |
Adecco (Group) |
Switzerland |
Alexander, Jan (Belgian Growth Fund 202007) |
Investment Manager |
Belgian Growth Fund (BGF) |
Belgium |
Alexander, Robert (ZS Pharma 201511 CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
United States (USA) |
Alexander, Sebastian (Chorlex Pharmaceuticals GmbH 201511– Managing Director) |
Managing Director |
Chorlex Pharmaceuticals GmbH |
Germany |
Alexandre, Leslie (Life Science Washington 202108 CEO) |
Chief Executive Officer (CEO) |
Life Science Washington |
United States (USA) |
Alexandrov, Alexander (MYR GmbH 201203 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Gilead Sciences (Group) |
Germany |
Alexandrov, Theodore (EMBL 201410– Team Leader at EMBL Heidelberg before Univ Bremen) |
Researcher (university / research institute) |
EMBL (European Molecular Biology Laboratory) |
Germany |
Alexandrova, Natalia (Ariadne Genomics 200605) |
n. a. |
Reed Elsevier (Group) |
United States (USA) |
Alexanyan, Vladimir (Valtex 1982– Founder) |
Company Founder |
Valtex (Group) |
United States (USA) |
Alfaiate, Maria (Lundbeck 202408– EVP Commercial + Corporate Strategy before Bayer + AstraZeneca + MSD/Merck) |
Business Development Manager / Strategy Manager |
Lundbeck (Group) |
Denmark |
Alfheim, Jan A. (Oncoinvent 202006 CEO) |
Chief Executive Officer (CEO) |
Oncoinvent AS |
Norway |
Alfón, José (Ability Pharmaceuticals 201504 VP RnD) |
Research & Development Manager |
Ability Pharmaceuticals S.L. (AbilityPharma) |
Spain (España) |
Alghabban, Amer (Merck (DE) 201402 Director Global Quality Assurance Auditing of Merck Serono) |
n. a. |
Merck (DE) (Group) |
Germany |
Ali, Batoul (Instinctif Partners 202305) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
Ali, Iraj (Achilles Therapeutics 201812– CEO before Interim CEO + Syncona + McKinsey) |
Chief Executive Officer (CEO) |
Achilles Therapeutics (Group) |
United Kingdom (GB) |
Ali, Mohammed (Boehringer 202002 Global Head of Digital Development Global Clinical Operations) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
Alici, Aysel (Caprotec 201210 Sales Manager) |
Sales Manager / Marketing Manager |
Caprotec Bioanalytics GmbH |
Germany |
Alilovic, Sasa (Sascha) (SHS 202004– Managing Partner joined 2018 as Partner before MorphoSys + Siemens) |
Managing Partner (investment firm) |
SHS Capital (Group) |
Germany |
Allaer, Didier (Diagenode 201105 CEO) |
Chief Executive Officer (CEO) |
Hologic (Group) |
Belgium |
Allan, Eva-Lotta (Immunocore 201305– CBO before Ablynx 200606– CBO before Vertex Pharmaceuticals) |
Chief Business Officer (CBO) |
Immunocore (Group) |
United Kingdom (GB) |
Allan, Rich (Trout Group 201903) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |